Menu
Log in
Forgot password


Log in
Forgot password

RARE HISTIOCYTOSES STEERING COMMITTEE

The Rare Histiocytoses Steering Committee is responsible for charting strategic direction of the HS in their specified areas, including conduct of clinical trials and engagement with the broader group of investigators interested in rare histiocytoses.

Jean-Francoise Emile - Chair
Versailles University, Paris-Saclay University - Boulogne, France
Term of Office: 2021 - 2025

Oussama Abla 
The Hospital for Sick Children – Toronto, ON, Canada
Term of Office: 2020 - 2024

Jorge Braier
Hospital Garahan – Buenos Aires, Argentina
Term of Office: 2020 - 2024

Eli Diamond
Memorial Sloan Kettering Cancer Center - New York, NY, USA
Term of Office: 2023 - 2027

Benjamin Durham
Memorial Sloan Kettering Cancer Center - New York, NY USA
Term of Office: 2021 - 2025

Gaurav Goyal
University of Alabama at Birmingham - Birmingham, AL USA
Term of Office: 2020 - 2024




Julien Haroche
Hopital Pitie-Salpetriere - Paris, France
Term of Office: 2022 - 2026

Zdenka Krenova
University Children Hospital, Brno, ICRC Brno - Brno, Czech Republic
Term of Office: 2023 - 2027

Akira Morimoto
Jichi Medical University - Shimotsuke, Japan
Term of Office: 2021 - 2025

Jennifer Picarsic
Cincinnati Children’s Hospital Medical Center - Cincinnati, OH, USA
Term of Office: 2023 - 2027

Karen Rech
Mayo Clinic - Rochester, MN, USA
Term of Office: 2023 - 2027



Office: +1 (856) 589-6606
Fax: +1 (856) 589-6614
Email: [email protected]

Histiocyte Society
332 N Broadway
Pitman, NJ 08071 USA

Powered by Wild Apricot Membership Software